Isothermal Nucleic Acid Amplification Technology Market Size Worth $10.34 Billion By 2030 | CAGR: 12.2%

The global isothermal nucleic acid amplification technology market size is expected to reach USD 10.34 billion by 2030, according to a new study by Polaris Market Research. The report “Isothermal Nucleic Acid Amplification Technology Market Share, Size, Trends, Industry Analysis Report, By Product (Assay, Kits, Reagents and Systems); By Type; By Application; By End-Use; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides an analysis of future market growth.

The growing demand for the method in the healthcare sector for disease diagnosis is expected to drive market growth. Furthermore, penetration of the technique due to its rapid results and cost-effective nature compared to the conventional method is one of the significant factors fueling the market demand.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-market/request-for-sample

In addition, the advancement of DNA amplification technologies and emphasis on research has created a lucrative opportunity in the cancer therapy field, contributing to the demand for the technology. Furthermore, the increase in medical consumption and penetration of novel technologies to develop gene-based drugs is anticipated to propel market growth.

The COVID-19 pandemic had a positive impact on the demand for isothermal nucleic acid amplification technology as it provides quick and accurate results, and the kits were less time-consuming and required no supervision to perform the test. Moreover, the isothermal kits were commercially used in urban and rural areas to detect the SARS-CoV-2 virus.

Isothermal Nucleic Acid Amplification Technology Market Report Highlights

• The demand for assays, kits, and reagents is due to the rising number of cost-efficient molecular diagnostics solutions, which is expected to drive product demand.
• The transcription-mediated amplification method accounted for the highest revenue share and is expected to continue its dominance due to its wide range of applications in pathogen detection in clinical and environmental samples.
• Blood screening is the second largest segment to witness growth as it detects and provides comprehensive data on health issues at the early stage.
• Asia Pacific is expected to grow over the forecast period owing to the introduction of new and innovative isothermal kits and R&D funding to carry out genome research.

• Major players operating in the market include PPG Industries Inc., Abbott, Alere Inc., Becton, Dickson & Company, Biohelix Corporation, Biomerieux Biotechnology Company, Eiken Chemical Co. Ltd, Grifols S.A., Hologic Gene-Probe, Lucigen Corporation, Meridian Biosciences, Inc., Nugen, Optigene Limited, QIAGEN Company, Quidel Corporation, Tecan Genomics Inc., Thermos Fisher Scientific, Inc., Ustar Biotechnologies Ltd.

Polaris Market Research has segmented the isothermal nucleic acid amplification technology market report based on product, type, application, end-use, and region:

Isothermal Nucleic Acid Amplification Technology, Product Outlook (Revenue – USD Billion, 2018 - 2030)

• Assay, Kits and Reagents
• Systems

Isothermal Nucleic Acid Amplification Technology, Type Outlook (Revenue - USD Billion, 2018 - 2030)

• TMA
• LAMP
• SDA
• HAD
• NASBA
• Others

Isothermal Nucleic Acid Amplification Technology, Application Outlook (Revenue - USD Billion, 2018 - 2030)

• Infectious Disease Diagnosis
• Hepatitis
• CT/NG
• HIV
• Influenza
• Blood Screening
• Others

Isothermal Nucleic Acid Amplification Technology, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

• Hospital
• Reference Laboratories
• Academic & Research Institutes
• Others

Isothermal Nucleic Acid Amplification Technology, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
• Latin America
  • Argentina
  • Brazil
  • Mexico
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa